Omega Fund Management
Latest statistics and disclosures from Omega Fund Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are LXEO, REPL, NUVB, ENGN, MORF, and represent 78.10% of Omega Fund Management's stock portfolio.
- Added to shares of these 3 stocks: LXEO (+$29M), ENGN (+$10M), ENGNW.
- Started 3 new stock positions in LXEO, ENGNW, ENGN.
- Reduced shares in these 1 stock: ALPN.
- Sold out of its position in ALPN.
- Omega Fund Management was a net buyer of stock by $38M.
- Omega Fund Management has $123M in assets under management (AUM), dropping by 13.37%.
- Central Index Key (CIK): 0001637359
Tip: Access up to 7 years of quarterly data
Positions held by Omega Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 14 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Lexeo Therapeutics Common Stock (LXEO) | 23.5 | $29M | NEW | 2.2M | 13.42 |
|
| Replimune Group Common Stock (REPL) | 20.5 | $25M | 3.0M | 8.43 |
|
|
| Nuvation Bio Common Stock Class A (NUVB) | 18.4 | $23M | 15M | 1.51 |
|
|
| enGene Holdings Common Stock (ENGN) | 8.5 | $10M | NEW | 1.1M | 9.23 |
|
| Morphic Holding Common Stock (MORF) | 7.2 | $8.9M | 310k | 28.88 |
|
|
| Spruce Biosciences Common Stock (SPRB) | 5.1 | $6.3M | 2.2M | 2.93 |
|
|
| Kronos Bio Common Stock (KRON) | 3.9 | $4.8M | 3.8M | 1.25 |
|
|
| Ikena Oncology Common Stock (IKNA) | 3.6 | $4.4M | 2.2M | 1.97 |
|
|
| Sana Biotechnology Common Stock (SANA) | 2.8 | $3.4M | 844k | 4.08 |
|
|
| Theseus Pharmaceuticals Common Stock | 2.3 | $2.9M | 712k | 4.05 |
|
|
| Immunic Common Stock (IMUX) | 2.2 | $2.7M | 1.8M | 1.50 |
|
|
| Syros Pharmaceuticals Common Stock (SYRS) | 1.6 | $2.0M | 251k | 7.79 |
|
|
| enGene Holdings Warrant (ENGNW) | 0.3 | $404k | NEW | 475k | 0.85 |
|
| Senti Biosciences Common Stock (SNTI) | 0.1 | $129k | 196k | 0.66 |
|
Past Filings by Omega Fund Management
SEC 13F filings are viewable for Omega Fund Management going back to 2014
- Omega Fund Management 2023 Q4 filed Feb. 14, 2024
- Omega Fund Management 2023 Q3 filed Nov. 14, 2023
- Omega Fund Management 2023 Q2 filed Aug. 14, 2023
- Omega Fund Management 2023 Q1 filed May 15, 2023
- Omega Fund Management 2022 Q4 filed Feb. 13, 2023
- Omega Fund Management 2022 Q3 filed Nov. 14, 2022
- Omega Fund Management 2022 Q2 filed Aug. 15, 2022
- Omega Fund Management 2022 Q1 filed May 13, 2022
- Omega Fund Management 2021 Q4 filed Feb. 14, 2022
- Omega Fund Management 2021 Q3 filed Nov. 15, 2021
- Omega Fund Management 2021 Q1 amended filed Nov. 15, 2021
- Omega Fund Management 2021 Q2 amended filed Nov. 15, 2021
- Omega Fund Management 2021 Q2 filed Aug. 16, 2021
- Omega Fund Management 2021 Q1 filed May 17, 2021
- Omega Fund Management 2020 Q4 filed Feb. 16, 2021
- Omega Fund Management 2020 Q3 filed Nov. 16, 2020